ArticleOncotarget2017

The effect of the JAK2 inhibitor TG101209 against T cell acute lymphoblastic leukemia (T-ALL) is mediated by inhibition of JAK-STAT signaling and activation of the crosstalk between apoptosis and autophagy signaling.

Zhao Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.